ArticleEndocrine pathology2026
Three-Tier Prognostic Stratification of Lung Carcinoids (NET G1-G2-G3) by Multivariable, Data-Driven Integration of Ki-67 and Mitotic Count.
Article in Endocrine pathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pulmonary neuroendocrine tumors (NETs) include typical and atypical carcinoids, corresponding to low- and intermediate-grade malignancies. Integration of necrosis, mitotic count per 2 mm² (MC), and Ki-67 index, a desirable criterion in the current WHO scheme, may enable a classification framework beyond conventional histology. We used a clustering method for mixed-type data, including necrosis, MC and Ki-67 index, on a single-institution cohort of 358 typical and 125 atypical carcinoids with long-term follow-up. An external validation series of 259 additional carcinoids was used. A three-cluster solution was selected, yielding a tiered prognostic stratification model, that included NETG1 (383 cases; mean MC: 0.7; necrosis: 8.1% of cases; mean Ki-67 index: 2.5%), NETG2 (77 cases; mean MC 2.3; necrosis 27.3%; mean Ki-67: 11.4%), and NETG3 (23 cases; mean MC: 5.5; necrosis 60.9%; mean Ki-67: 25.1%). The model was independent of histological classification. Ki-67 index was the strongest discriminator, distinguishing NET G1 tumors with a Ki-67 index < 6% from NET G3 tumors (Ki-67 > 16%), while MC contributed to identifying a subset of NET G2 tumors. The selected cut-offs were derived through a statistical approach evaluating hundreds of decision-tree configurations, following a sequential algorithm from Ki-67 to MC, with 6-16% identified as the most informative Ki-67 range for intermediate stratification. Necrosis added no discriminative value, as it was closely correlated with the Ki-67 index and MC. This classification corresponded to a progressive worsening of overall survival and, more significantly, relapse-free survival, and it was transferable to the external cohort. In conclusion, based on routinely available pathological parameters, this model provides a practical and reproducible classification of resected pulmonary NETs, overcoming the traditional typical-atypical carcinoid dichotomy and is potentially applicable to biopsy material.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.